(S)-amphetamine decreases expression EXP 6480464 Dextroamphetamine results in decreased expression of FGFR1 mRNA CTD PMID:12558987 1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of FGFR1 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of FGFR1 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of FGFR1 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:732290 6480464 Estradiol results in decreased expression of FGFR1 mRNA CTD PMID:19167446 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of FGFR1 mRNA CTD PMID:17023530 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:732290 6480464 2 more ... CTD PMID:19095052 2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of FGFR1 mRNA] CTD PMID:15667827 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732290 6480464 Tetrachlorodibenzodioxin results in decreased expression of FGFR1 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FGFR1 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FGFR1 mRNA CTD PMID:17586704 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:620713 6480464 Glucosamine inhibits the reaction [IL1B results in decreased expression of FGFR1 mRNA] CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:620713 6480464 Glucosamine results in increased expression of FGFR1 mRNA CTD PMID:17109745 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of FGFR1 mRNA CTD PMID:16150908 3,3',5-triiodo-L-thyronine increases expression ISO RGD:620713 6480464 Triiodothyronine results in increased expression of FGFR1 mRNA, Triiodothyronine results in increased expression of FGFR1 protein CTD PMID:12805413 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:620713 6480464 Cycloheximide inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] more ... CTD PMID:12805413 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of FGFR1 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732290 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FGFR1 mRNA CTD PMID:28628672 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR1 mRNA CTD PMID:31009676 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of FGFR1 mRNA CTD PMID:20713471 , PMID:29554273 4,4'-sulfonyldiphenol multiple interactions ISO RGD:732290 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of FGFR1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FGFR1 mRNA CTD PMID:28628672 , PMID:31601247 4-hydroxynon-2-enal decreases expression ISO RGD:732290 6480464 4-hydroxy-2-nonenal results in decreased expression of FGFR1 mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of FGFR1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of FGFR1 mRNA CTD PMID:27915011 5-aza-2'-deoxycytidine decreases expression ISO RGD:732290 6480464 Decitabine results in decreased expression of FGFR1 mRNA CTD PMID:17785578 6-propyl-2-thiouracil decreases expression ISO RGD:620713 6480464 Propylthiouracil results in decreased expression of FGFR1 mRNA CTD PMID:24780913 acrolein multiple interactions ISO RGD:732290 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of FGFR1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of FGFR1 mRNA CTD PMID:32699268 acrylamide multiple interactions ISO RGD:732290 6480464 Acrylamide analog promotes the reaction [FGFR1 protein binds to FGFR1 protein] CTD PMID:14733594 actinomycin D multiple interactions ISO RGD:620713 6480464 Dactinomycin inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] CTD PMID:12805413 Aflatoxin B2 alpha decreases methylation ISO RGD:732290 6480464 aflatoxin B2 results in decreased methylation of FGFR1 intron CTD PMID:30157460 aldehydo-D-glucosamine multiple interactions ISO RGD:620713 6480464 Glucosamine inhibits the reaction [IL1B results in decreased expression of FGFR1 mRNA] CTD PMID:17109745 aldehydo-D-glucosamine increases expression ISO RGD:620713 6480464 Glucosamine results in increased expression of FGFR1 mRNA CTD PMID:17109745 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of FGFR1 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO RGD:732290 6480464 Tretinoin results in decreased expression of FGFR1 mRNA CTD PMID:15498508 all-trans-retinoic acid affects expression ISO RGD:732290 6480464 Tretinoin affects the expression of FGFR1 mRNA CTD PMID:15498508 all-trans-retinoic acid increases expression ISO RGD:620713 6480464 Tretinoin results in increased expression of FGFR1 protein CTD PMID:15389522 alpha-pinene multiple interactions ISO RGD:732290 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of FGFR1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of FGFR1 mRNA CTD PMID:32699268 ammonium chloride affects expression ISO RGD:620713 6480464 Ammonium Chloride affects the expression of FGFR1 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:732290 6480464 Antirheumatic Agents results in increased expression of FGFR1 mRNA CTD PMID:24449571 AP20187 increases activity EXP 6480464 AP20187 results in increased activity of FGFR1 protein mutant form CTD PMID:12654294 arsenous acid multiple interactions ISO RGD:732290 6480464 Arsenic Trioxide promotes the reaction [PD 173074 results in decreased expression of FGFR1 protein], PD 173074 promotes the reaction [Arsenic Trioxide results in decreased expression of FGFR1 protein] CTD PMID:27794399 arsenous acid increases expression ISO RGD:732290 6480464 Arsenic Trioxide results in increased expression of FGFR1 mRNA CTD PMID:17258074 , PMID:20458559 arsenous acid decreases phosphorylation ISO RGD:732290 6480464 Arsenic Trioxide results in decreased phosphorylation of FGFR1 protein mutant form CTD PMID:17027752 arsenous acid decreases response to substance ISO RGD:732290 6480464 FGFR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:27794399 arsenous acid decreases expression ISO RGD:732290 6480464 Arsenic Trioxide results in decreased expression of FGFR1 mRNA, Arsenic Trioxide results in decreased expression of FGFR1 protein CTD PMID:15761015 more ... benzo[a]pyrene increases mutagenesis ISO RGD:732290 6480464 Benzo(a)pyrene results in increased mutagenesis of FGFR1 gene CTD PMID:25435355 benzo[a]pyrene increases expression ISO RGD:732290 6480464 Benzo(a)pyrene results in increased expression of FGFR1 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:732290 6480464 Benzo(a)pyrene results in increased methylation of FGFR1 5' UTR, Benzo(a)pyrene results in increased methylation of FGFR1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:732290 6480464 Benzo(a)pyrene results in decreased expression of FGFR1 mRNA CTD PMID:22316170 , PMID:26238291 beta-D-glucosamine multiple interactions ISO RGD:620713 6480464 Glucosamine inhibits the reaction [IL1B results in decreased expression of FGFR1 mRNA] CTD PMID:17109745 beta-D-glucosamine increases expression ISO RGD:620713 6480464 Glucosamine results in increased expression of FGFR1 mRNA CTD PMID:17109745 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:732290 6480464 Diethylhexyl Phthalate results in decreased expression of FGFR1 mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:732290 6480464 bisphenol A results in increased expression of FGFR1 mRNA CTD PMID:20678512 bisphenol A decreases methylation ISO RGD:732290 6480464 bisphenol A results in decreased methylation of FGFR1 gene CTD PMID:31601247 bisphenol A increases methylation ISO RGD:620713 6480464 bisphenol A results in increased methylation of FGFR1 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:620713 6480464 bisphenol A results in increased expression of FGFR1 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FGFR1 mRNA CTD PMID:26063408 , PMID:32156529 bisphenol A multiple interactions ISO RGD:620713 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR1 mRNA CTD PMID:25607892 Butylparaben multiple interactions ISO RGD:620713 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR1 mRNA CTD PMID:25607892 cadmium atom increases expression ISO RGD:732290 6480464 Cadmium results in increased expression of FGFR1 mRNA CTD PMID:23369406 cadmium dichloride decreases expression ISO RGD:732290 6480464 Cadmium Chloride results in decreased expression of FGFR1 mRNA CTD PMID:12760830 cadmium dichloride decreases methylation ISO RGD:620713 6480464 Cadmium Chloride results in decreased methylation of FGFR1 promoter CTD PMID:22457795 calcitriol multiple interactions ISO RGD:620713 6480464 [Calcium co-treated with Calcitriol] affects the expression of FGFR1 mRNA CTD PMID:15913539 calcitriol decreases expression ISO RGD:732290 6480464 Calcitriol results in decreased expression of FGFR1 mRNA CTD PMID:26485663 calcium atom multiple interactions ISO RGD:620713 6480464 [Calcium co-treated with Calcitriol] affects the expression of FGFR1 mRNA CTD PMID:15913539 calcium(0) multiple interactions ISO RGD:620713 6480464 [Calcium co-treated with Calcitriol] affects the expression of FGFR1 mRNA CTD PMID:15913539 capsaicin decreases expression ISO RGD:620713 6480464 Capsaicin results in decreased expression of FGFR1 protein CTD PMID:14521749 carbamazepine affects expression ISO RGD:732290 6480464 Carbamazepine affects the expression of FGFR1 mRNA CTD PMID:24752500 CGP 52608 multiple interactions ISO RGD:732290 6480464 CGP 52608 promotes the reaction [RORA protein binds to FGFR1 gene] CTD PMID:28238834 chlorpromazine decreases expression ISO RGD:732290 6480464 Chlorpromazine analog results in decreased expression of FGFR1 mRNA CTD PMID:15924885 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FGFR1 gene CTD PMID:20938992 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of FGFR1 mRNA CTD PMID:21151649 cisplatin multiple interactions ISO RGD:732290 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of FGFR1 mRNA], jinfukang promotes the reaction [Cisplatin results in decreased expression of FGFR1 mRNA] CTD PMID:27392435 cisplatin decreases expression ISO RGD:732290 6480464 Cisplatin results in decreased expression of FGFR1 mRNA CTD PMID:27392435 cocaine increases expression ISO RGD:620713 6480464 Cocaine results in increased expression of FGFR1 mRNA CTD PMID:16076954 colforsin daropate hydrochloride increases expression ISO RGD:732290 6480464 Colforsin results in increased expression of FGFR1 mRNA CTD PMID:10320526 copper atom multiple interactions ISO RGD:732290 6480464 [Chelating Agents binds to Copper] which affects the expression of FGFR1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:732290 6480464 [Chelating Agents binds to Copper] which affects the expression of FGFR1 mRNA CTD PMID:30911355 copper(II) chloride affects expression ISO RGD:732290 6480464 cupric chloride affects the expression of FGFR1 mRNA CTD PMID:17211630 coumestrol decreases expression ISO RGD:732290 6480464 Coumestrol results in decreased expression of FGFR1 mRNA CTD PMID:19167446 crizotinib multiple interactions ISO RGD:732290 6480464 [PD 173074 results in decreased activity of FGFR1 protein] inhibits the reaction [[crizotinib results in decreased phosphorylation of MET protein] which results in increased expression of HGF protein] CTD PMID:22683780 crocidolite asbestos decreases expression ISO RGD:732290 6480464 Asbestos, Crocidolite results in decreased expression of FGFR1 mRNA CTD PMID:23634900 Cuprizon increases expression ISO RGD:620713 6480464 Cuprizone results in increased expression of FGFR1 mRNA CTD PMID:26577399 , PMID:27523638 cycloheximide multiple interactions ISO RGD:620713 6480464 Cycloheximide inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] CTD PMID:12805413 cyclosporin A decreases expression ISO RGD:732290 6480464 Cyclosporine results in decreased expression of FGFR1 mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression ISO RGD:620713 6480464 decabromobiphenyl ether results in decreased expression of FGFR1 mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:732290 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FGFR1 mRNA CTD PMID:28628672 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR1 mRNA CTD PMID:31009676 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGFR1 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:732290 6480464 Arsenic Trioxide results in decreased expression of FGFR1 mRNA, Arsenic Trioxide results in decreased expression of FGFR1 protein CTD PMID:15761015 more ... diarsenic trioxide decreases response to substance ISO RGD:732290 6480464 FGFR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:27794399 diarsenic trioxide increases expression ISO RGD:732290 6480464 Arsenic Trioxide results in increased expression of FGFR1 mRNA CTD PMID:17258074 , PMID:20458559 diarsenic trioxide decreases phosphorylation ISO RGD:732290 6480464 Arsenic Trioxide results in decreased phosphorylation of FGFR1 protein mutant form CTD PMID:17027752 diarsenic trioxide multiple interactions ISO RGD:732290 6480464 Arsenic Trioxide promotes the reaction [PD 173074 results in decreased expression of FGFR1 protein], PD 173074 promotes the reaction [Arsenic Trioxide results in decreased expression of FGFR1 protein] CTD PMID:27794399 diazinon decreases expression ISO RGD:620713 6480464 Diazinon results in decreased expression of FGFR1 mRNA CTD PMID:17589599 diazinon increases expression ISO RGD:620713 6480464 Diazinon results in increased expression of FGFR1 mRNA CTD PMID:19130878 dibutyl phthalate decreases expression ISO RGD:620713 6480464 Dibutyl Phthalate results in decreased expression of FGFR1 mRNA CTD PMID:21266533 diclofenac affects expression ISO RGD:732290 6480464 Diclofenac affects the expression of FGFR1 mRNA CTD PMID:24752500 dieldrin affects expression ISO RGD:620713 6480464 Dieldrin affects the expression of FGFR1 mRNA CTD PMID:19130878 dimethylarsinous acid decreases expression ISO RGD:732290 6480464 dimethylarsinous acid results in decreased expression of FGFR1 mRNA CTD PMID:16507463 diuron decreases expression ISO RGD:620713 6480464 Diuron results in decreased expression of FGFR1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:732290 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732290 6480464 Doxorubicin results in decreased expression of FGFR1 mRNA CTD PMID:29803840 ellagic acid decreases expression ISO RGD:732290 6480464 Ellagic Acid results in decreased expression of FGFR1 mRNA CTD PMID:12002526 entinostat increases expression ISO RGD:732290 6480464 entinostat results in increased expression of FGFR1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:732290 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR1 mRNA CTD PMID:27188386 enzacamene multiple interactions ISO RGD:620713 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR1 mRNA CTD PMID:25607892 ethanol increases expression ISO RGD:620713 6480464 Ethanol results in increased expression of FGFR1 protein CTD PMID:29769550 ethanol increases expression EXP 6480464 Ethanol results in increased expression of FGFR1 mRNA CTD PMID:30319688 ethanol affects expression EXP 6480464 Ethanol affects the expression of FGFR1 mRNA CTD PMID:30319688 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of FGFR1 mRNA CTD PMID:30319688 ethyl trans-caffeate affects expression ISO RGD:732290 6480464 ethyl caffeate affects the expression of FGFR1 protein CTD PMID:24892518 fenamidone increases expression EXP 6480464 fenamidone results in increased expression of FGFR1 mRNA CTD PMID:27029645 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FGFR1 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:732290 6480464 Folic Acid results in decreased expression of FGFR1 mRNA CTD PMID:21867686 formaldehyde increases expression ISO RGD:732290 6480464 Formaldehyde results in increased expression of FGFR1 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:732290 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of FGFR1 gene CTD PMID:31601247 furan increases expression ISO RGD:620713 6480464 furan results in increased expression of FGFR1 mRNA CTD PMID:27387713 gamma-tocopherol decreases expression ISO RGD:732290 6480464 Tocopherols results in decreased expression of FGFR1 mRNA CTD PMID:15144885 heparan sulfate affects binding ISO RGD:732290 6480464 FGF1 protein binds to Heparitin Sulfate binds to FGFR1 protein CTD PMID:12604602 heparan sulfate increases activity EXP 6480464 Heparitin Sulfate analog results in increased activity of FGFR1 protein alternative form CTD PMID:12460940 heparin affects binding ISO RGD:732290 6480464 Heparin binds to FGFR1 protein binds to FGF2 protein CTD PMID:15096041 heparin multiple interactions EXP 6480464 Heparin promotes the reaction [FGFR1 protein binds to FGF1 protein], Heparin promotes the reaction [FGFR1 protein binds to FGF2 protein] CTD PMID:1379594 hydrogen peroxide multiple interactions ISO RGD:732290 6480464 Hydrogen Peroxide promotes the reaction [FGF2 protein binds to FGFR1 protein] CTD PMID:8849686 hydrogen peroxide decreases expression ISO RGD:732290 6480464 Hydrogen Peroxide results in decreased expression of FGFR1 mRNA CTD PMID:12419474 indometacin multiple interactions ISO RGD:732290 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FGFR1 mRNA CTD PMID:28628672 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FGFR1 mRNA CTD PMID:36331819 isotretinoin increases expression ISO RGD:732290 6480464 Isotretinoin results in increased expression of FGFR1 mRNA CTD PMID:20436886 kainic acid increases expression ISO RGD:620713 6480464 Kainic Acid results in increased expression of FGFR1 mRNA CTD PMID:7649223 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FGFR1 gene CTD PMID:20938992 lead diacetate multiple interactions ISO RGD:732290 6480464 [lead acetate co-treated with zinc protoporphyrin] results in increased expression of FGFR1 mRNA CTD PMID:22839698 lenalidomide affects expression ISO RGD:732290 6480464 Lenalidomide affects the expression of FGFR1 mRNA CTD PMID:30834740 malathion increases expression ISO RGD:732290 6480464 Malathion results in increased expression of FGFR1 mRNA CTD PMID:32069766 methotrexate affects response to substance ISO RGD:732290 6480464 FGFR1 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methylmercury chloride affects expression EXP 6480464 methylmercuric chloride affects the expression of FGFR1 mRNA CTD PMID:21613230 methylmercury chloride increases expression ISO RGD:732290 6480464 methylmercuric chloride results in increased expression of FGFR1 mRNA CTD PMID:28001369 morphine increases expression ISO RGD:620713 6480464 Morphine results in increased expression of FGFR1 mRNA CTD PMID:15183518 N-methyl-N-nitrosourea multiple interactions ISO RGD:620713 6480464 Methylnitrosourea results in increased expression of and affects the localization of FGFR1 protein CTD PMID:15581186 N-nitrosodiethylamine increases response to substance EXP 6480464 FGFR1 protein results in increased susceptibility to Diethylnitrosamine CTD PMID:19009564 orantinib multiple interactions ISO RGD:732290 6480464 orantinib results in decreased phosphorylation of and results in decreased activity of FGFR1 protein CTD PMID:16144927 oxaliplatin increases expression ISO RGD:620713 6480464 oxaliplatin results in increased expression of FGFR1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:620713 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FGFR1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:732290 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of FGFR1 mRNA more ... CTD PMID:32699268 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FGFR1 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:732290 6480464 Acetaminophen results in increased expression of FGFR1 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol increases expression ISO RGD:620713 6480464 Acetaminophen results in increased expression of FGFR1 mRNA CTD PMID:33387578 paraoxon decreases expression ISO RGD:732290 6480464 Paraoxon results in decreased expression of FGFR1 mRNA CTD PMID:24413757 PD-166866 decreases activity ISO RGD:732290 6480464 PD 166866 results in decreased activity of FGFR1 protein CTD PMID:15522930 PD-166866 multiple interactions ISO RGD:620713 6480464 PD 166866 inhibits the reaction [FGF1 protein results in increased expression of FGFR1 protein], PD 166866 inhibits the reaction [FGFR1 protein results in increased phosphorylation of FGFR1 protein] CTD PMID:12805413 , PMID:15773903 PD173074 decreases activity ISO RGD:732290 6480464 PD 173074 results in decreased activity of FGFR1 protein CTD PMID:22683780 , PMID:27794399 PD173074 decreases expression ISO RGD:732290 6480464 PD 173074 results in decreased expression of FGFR1 protein CTD PMID:27794399 PD173074 multiple interactions ISO RGD:732290 6480464 [PD 173074 results in decreased activity of FGFR1 protein] inhibits the reaction [[crizotinib results in decreased phosphorylation of MET protein] which results in increased expression of HGF protein] more ... CTD PMID:22683780 , PMID:27794399 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FGFR1 mRNA CTD PMID:36331819 peroxynitrous acid affects response to substance ISO RGD:620713 6480464 FGFR1 protein alternative form affects the susceptibility to Peroxynitrous Acid CTD PMID:12573278 piperine affects binding ISO RGD:732290 6480464 piperine binds to FGFR1 protein CTD PMID:28341137 pirinixic acid increases expression ISO RGD:620713 6480464 pirinixic acid results in increased expression of FGFR1 mRNA CTD PMID:12832660 pomalidomide decreases expression ISO RGD:732290 6480464 pomalidomide results in decreased expression of FGFR1 mRNA CTD PMID:30834740 ponatinib decreases activity ISO RGD:732290 6480464 ponatinib analog results in decreased activity of FGFR1 protein more ... CTD PMID:19878872 , PMID:21561767 ponatinib decreases phosphorylation ISO RGD:732290 6480464 ponatinib results in decreased phosphorylation of FGFR1 protein mutant form CTD PMID:21482694 , PMID:22875613 resveratrol increases expression ISO RGD:732290 6480464 resveratrol results in increased expression of FGFR1 mRNA CTD PMID:12002526 Salinomycin decreases expression ISO RGD:732290 6480464 salinomycin results in decreased expression of FGFR1 mRNA CTD PMID:19682730 SB 431542 multiple interactions ISO RGD:732290 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of FGFR1 mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:732290 6480464 sodium arsenite results in decreased expression of FGFR1 mRNA CTD PMID:21281968 sodium arsenite decreases expression ISO RGD:620713 6480464 sodium arsenite results in decreased expression of FGFR1 mRNA CTD PMID:16876216 more ... sodium dichromate decreases expression ISO RGD:732290 6480464 sodium bichromate results in decreased expression of FGFR1 mRNA CTD PMID:12760830 streptozocin decreases expression ISO RGD:620713 6480464 Streptozocin results in decreased expression of FGFR1 CTD PMID:24136780 streptozocin multiple interactions ISO RGD:620713 6480464 rosiglitazone inhibits the reaction [Streptozocin results in decreased expression of FGFR1] CTD PMID:24136780 sunitinib decreases expression ISO RGD:732290 6480464 Sunitinib results in decreased expression of FGFR1 mRNA CTD PMID:31533062 tamibarotene decreases expression ISO RGD:732290 6480464 tamibarotene results in decreased expression of FGFR1 mRNA CTD PMID:15498508 tamoxifen decreases response to substance ISO RGD:732290 6480464 FGFR1 protein results in decreased susceptibility to Tamoxifen CTD PMID:20179196 taurine decreases expression ISO RGD:732290 6480464 Taurine results in decreased expression of FGFR1 mRNA CTD PMID:16579726 testosterone increases expression EXP 6480464 Testosterone results in increased expression of FGFR1 mRNA CTD PMID:7536664 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FGFR1 mRNA CTD PMID:17484886 thalidomide affects expression ISO RGD:732290 6480464 Thalidomide affects the expression of FGFR1 mRNA CTD PMID:30834740 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGFR1 mRNA CTD PMID:29950665 tocopherol decreases expression ISO RGD:732290 6480464 Tocopherols results in decreased expression of FGFR1 mRNA CTD PMID:15144885 topotecan multiple interactions ISO RGD:620713 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FGFR1 mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:620713 6480464 Topotecan results in increased expression of FGFR1 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:620713 6480464 Trichloroethylene results in increased expression of FGFR1 mRNA CTD PMID:33387578 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of FGFR1 mRNA CTD PMID:33045310 urea decreases activity ISO RGD:732290 6480464 Urea analog results in decreased activity of FGFR1 protein CTD PMID:16000000 urethane increases expression ISO RGD:732290 6480464 Urethane results in increased expression of FGFR1 mRNA CTD PMID:28818685 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of FGFR1 mRNA CTD PMID:19136453 valproic acid increases methylation ISO RGD:732290 6480464 Valproic Acid results in increased methylation of FGFR1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:732290 6480464 Valproic Acid results in increased expression of FGFR1 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:732290 6480464 Valproic Acid affects the expression of FGFR1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:732290 6480464 Valproic Acid results in decreased expression of FGFR1 mRNA CTD PMID:23179753 vinclozolin increases expression ISO RGD:620713 6480464 vinclozolin results in increased expression of FGFR1 mRNA CTD PMID:22615374 vinclozolin decreases methylation ISO RGD:620713 6480464 vinclozolin results in decreased methylation of FGFR1 gene CTD PMID:31682807 vorinostat decreases expression ISO RGD:732290 6480464 vorinostat results in decreased expression of FGFR1 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:732290 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR1 mRNA CTD PMID:27188386 zinc protoporphyrin multiple interactions ISO RGD:732290 6480464 [lead acetate co-treated with zinc protoporphyrin] results in increased expression of FGFR1 mRNA CTD PMID:22839698